Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 17, 2022

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions
Spinal Cord InjuriesAutonomic ImbalanceAutonomic DysreflexiaOrthostatic; Hypotension, Neurogenic
Interventions
DIAGNOSTIC_TEST

Tests of sympathetic inhibition

Bolus phenylephrine infusion using the Oxford technique will generate the need to inhibit sympathetic activity. Similarly, resting state Mayer waves will be assessed with regard to heart rate and blood pressure responses.

DIAGNOSTIC_TEST

Tests of sympathetic activation

Cold pressor test of the hand will be used to cause sympathetic activation. Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).

DIAGNOSTIC_TEST

Testing of autonomic dysreflexia

Cold pressor test of the foot and bladder pressor response (in individuals with SCI) will be tested.

DEVICE

Transcutaneous spinal cord stimulation

Transcutaneous spinal cord stimulation will be applied at T7-L1 spinal segments to assess alterations in autonomic neuroregulation.

Trial Locations (1)

02129

Spaulding Rehabilitation Hospital, Boston

All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

lead

Spaulding Rehabilitation Hospital

OTHER